Optimize Target Identification and MOA Studies

Correctly identifying drug targets and elucidating MOA is a critical stage in early drug development. Disease-relevant cell-based platforms are needed, which can quickly and easily transition to linked later stage ex vivo and in vivo models, for efficient go/no go preclinical program decisions.